The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing robust expansion, primarily fueled by the increasing prevalence of breast and lung cancers and surging investments in oncology research. Cancer therapeutics encompasses a comprehensive array of treatments designed to manage or cure cancer. Common therapeutic metrics include chemotherapy, radiation, immunotherapy, targeted therapy, hormone therapy, surgery, and stem cell therapy. Each of these strategies aims to eliminate or control the complexity of cancer cells, alleviate symptoms, and ultimately enhance patient survival. Depending on the specific type and stage of cancer, along with the patient's general health, multiple types of treatments are often combined to maximize therapeutic impact.

Cancer Therapeutics Market Segmentation Analysis

Key segments contributing to the cancer therapeutics market analysis are therapy type, indication, and distribution channel.

Regarding therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapeutic categories. Chemotherapy held the leading position in the market in 2024.

In terms of indications, the market is segmented across blood cancer, lung cancer, breast cancer, colorectum cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. Lung cancer accounted for the largest market share in 2024.

By distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the largest share of the market in 2024.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

According to the World Health Organization, roughly 1 in 6 deaths worldwide are caused by various forms of cancer. In 2022, there were an estimated 20 million new cancer cases and 9.7 million associated deaths; this burden is projected to increase by approximately 77% by 2050, placing further strain on health systems and communities. The American Cancer Society reports that 5–10% of all cancers are attributed to inherited genes. Numerous genes linked to cancer predisposition have been identified. For example, mutations in inherited cancer predisposition genes like BRCA1 and BRCA2 significantly increase the risk of developing breast, ovarian, and prostate cancers. Breast cancer is deemed the most prevalent cancer among women globally, with its incidence continuously rising due to factors such as environmental impact, genetic susceptibility, hormone imbalances, and lifestyle changes. It also remains one of the most prevalent cancers in the U.S.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications